These growth shares are my best buys for November

Appen Ltd (ASX:APX) shares and two others are my best growth picks for November after their declines last month…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

I think it is fair to say that October was a month to forget for Australian investors.

I'm optimistic that November will be significantly better and that a number of beaten down growth shares will recover some off their sizeable declines.

Three that I would consider buying are as follows:

Appen Ltd (ASX: APX)

This global leader in the development of high-quality, human annotated datasets for machine learning and artificial intelligence could be a great option in November. It was one of the worst performers on the Australia share market in October due to the tech selloff. While this was disappointing for shareholders, I believe it is a buying opportunity for non-shareholders. At present Appen's shares are changing hands at 27x estimated FY 2019 earnings. I think this is great value given its strong long-term growth potential.

Aristocrat Leisure Limited (ASX: ALL)

Another tech share that fell heavily last month was Aristocrat Leisure. But unlike many of its tech peers, I felt that its shares were already trading at an attractive price prior to the selloff. In light of this, I think they are arguably in the bargain bin now at just 20x estimated FY 2019 earnings. Especially given the solid growth potential of its fledgling digital business. Management believes this business is well positioned to address a broad spectrum of opportunities in the US$50 billion mobile gaming market.

Bellamy's Australia Ltd (ASX: BAL)

The Bellamy's share price is another growth share that fell heavily in October. However, this was largely down to disappointing guidance given for FY 2019. Management expects Australian label sales to be flat in FY 2019 due to the disruption caused by the launch of a new production formulation. While this is very underwhelming, I think investors should look beyond FY 2019 and to the future. At its annual general meeting management confirmed that it is targeting sales of $500 million by the end of FY 2021. This will be a 52% increase on FY 2018's result.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Appen Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Growth Shares

2 ASX shares highly recommended to buy: Experts

Multiple analysts rate these business as a buy, here’s why…

Read more »

A young woman uses a laptop and calculator while working from home.
Growth Shares

3 ASX growth shares I'd buy with $7,000

These ASX growth shares are building scalable platforms with room to grow.

Read more »

A couple are happy sitting on their yacht.
Growth Shares

What are the best Australian shares to buy now to try and make a million?

Looking to build wealth over the long-term? These shares could help.

Read more »

Purple tech growth chart.
Growth Shares

2 wonderful ASX All Ords stocks I'd buy today

These stocks could deliver great returns. Here’s why…

Read more »

Cheerful man in a orange shirt standing in front of an audience holding a tablet and using hand gestures to interact with the audience.
Growth Shares

3 amazing ASX growth shares that continue to stand out

Looking for growth options? Here are three to consider.

Read more »

Person pointing finger on on an increasing graph which represents a rising share price.
Growth Shares

2 ASX shares tipped to grow at least 50% in the next 12 months

These stocks could be some of the best ones to own today.

Read more »

Scared looking people on a rollercoaster ride representing volatility.
Growth Shares

What's driving the wild swings in Telix shares?

The ASX biotech stock offers high-growth potential, but it comes with volatility.

Read more »

An executive in a suit smooths his hair and laughs as he looks at his laptop feeling surprised and delighted.
Growth Shares

3 stellar ASX growth shares to buy now with 30% to 70% upside

Analysts have buy ratings and lofty price targets on these shares.

Read more »